Cover Image

Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment

Acute rejection episodes (ARE) of kidney transplants are considered as risk factor in the development of chronic rejection. In adult renal transplantation (RTx), ARE have been significantly reduced by mycophenolate mofetil (MMF) in combination with cyclosporin (CyA) and steroids (Pred). Reports of p...

Full description

Saved in:
Bibliographic Details
Main Authors: Staskewitz, Astrid (Author) , Kirste, Günter (Author) , Tönshoff, Burkhard (Author) , Weber, Lutz T. (Author) , Böswald, Michael (Author) , Burghard, Rainer (Author) , Helmchen, Udo (Author) , Brandis, Matthias (Author) , Zimmerhackl, Lothar B. (Author)
Format: Article (Journal)
Language:English
Published: March 15th, 2001
In: Transplantation
Year: 2001, Volume: 71, Issue: 5, Pages: 638-644
ISSN:1534-6080
Online Access:Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/transplantjournal/Fulltext/2001/03150/MYCOPHENOLATE_MOFETIL_IN_PEDIATRIC_RENAL.10.aspx
Get full text
Author Notes:Astrid Staskewitz, Günter Kirste, Burkhard Tönshoff, Lutz T. Weber, Michael Böswald, Rainer Burghard, Udo Helmchen, Matthias Brandis, Lothar B. Zimmerhackl
Description
Summary:Acute rejection episodes (ARE) of kidney transplants are considered as risk factor in the development of chronic rejection. In adult renal transplantation (RTx), ARE have been significantly reduced by mycophenolate mofetil (MMF) in combination with cyclosporin (CyA) and steroids (Pred). Reports of pediatric RTx on a maintenance immuno-suppression with MMF are restricted to patients (P) after antibody induction therapy.
Item Description:Gesehen am 26.01.2021
Physical Description:Online Resource
ISSN:1534-6080

Similar Items